Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Troels H. Jørgensen"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 6 (2019)
Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk. On the basis of the favorable outcomes of recent randomized clinical
Externí odkaz:
https://doaj.org/article/779819f21ea74765a38ce704f890c27e
Autor:
Henrik Nissen, Daniel Andreas Steinbrüchel, Petur Petursson, Bo Juel Kjeldsen, Nikolaj Ihlemann, Lars Søndergaard, Peter Skov Olsen, Troels H. Jørgensen, Hans Gustav Hørsted Thyregod
Publikováno v:
European Heart Journal
Jørgensen, T H, Thyregod, H G H, Ihlemann, N, Nissen, H, Petursson, P, Kjeldsen, B J, Steinbrüchel, D A, Olsen, P S & Søndergaard, L 2021, ' Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement ', European Heart Journal, vol. 42, no. 30, pp. 2912-2919 . https://doi.org/10.1093/eurheartj/ehab375
Jørgensen, T H, Thyregod, H G H, Ihlemann, N, Nissen, H, Petursson, P, Kjeldsen, B J, Steinbrüchel, D A, Olsen, P S & Søndergaard, L 2021, ' Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement ', European Heart Journal, vol. 42, no. 30, pp. 2912-2919 . https://doi.org/10.1093/eurheartj/ehab375
Aims The aims of the study were to compare clinical outcomes and valve durability after 8 years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk treated with either transcatheter aortic valve implantation (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f8e4732b8885d2d3f2a15f1a00462f
http://europepmc.org/articles/PMC8347457
http://europepmc.org/articles/PMC8347457
Autor:
Angelo Quagliana, Nicholas J. Montarello, Yannick Willemen, Pernille S. Bække, Troels H. Jørgensen, Ole De Backer, Lars Sondergaard
Publikováno v:
Journal of Clinical Medicine. 12:2136
Transcatheter aortic valve implantation (TAVR) is the first therapeutic option for elderly patients with severe symptomatic aortic stenosis, and indications are steadily expanding to younger patients and subjects with lower surgical risk and longer l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc074579e8661a2642a37e33736e85e
https://doi.org/10.3390/jcm12062136
https://doi.org/10.3390/jcm12062136
Autor:
Lars Soendergaard, Nynke H M Kooistra, Hafid Amrane, Miralem Pasic, Axel Unbehaun, Pieter R. Stella, Marco Spaziano, Martin J. Swaans, Thierry Lefèvre, Alexander Meyer, Nicola Buzzatti, Nikos Werner, Bakhtawar K. Mahmoodi, Giuseppe Bruschi, Jörg Kempfert, Georg Nickenig, Jan Malte Sinning, David Hildick-Smith, Jorn Brouwer, Vincent J. Nijenhuis, Azeem Latib, Carlo Zivelonghi, Troels H. Jørgensen, Marianna Adamo, Smriti Saraf, Jurriën M. ten Berg, A. Stundl
Publikováno v:
Catheterization and Cardiovascular Interventions. 97:1462-1469
OBJECTIVES We aimed to evaluate the effect of transcatheter aortic valve implantation (TAVI) approaches on mortality and identify effect modifiers and predictors for mortality. BACKGROUND Alternative access routes to transfemoral (TF) TAVI include th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c44b50504be93a9991af2e74f2fc348
https://doi.org/10.1002/ccd.29456
https://doi.org/10.1002/ccd.29456
Autor:
Lars Søndergaard, Troels H. Jørgensen, Nicolo Piazza, Ole De Backer, Bjarne L. Nørgaard, Jesper Møller Jensen, Nicolaj C. Hansson, Gintautas Bieliauskas, Christian Juhl Terkelsen, Jesper Hastrup Svendsen, Evald Høj Christiansen, Xi Wang
Publikováno v:
Jørgensen, T H, Hansson, N, De Backer, O, Bieliauskas, G, Terkelsen, C J, Wang, X, Jensen, J M, Christiansen, E H, Piazza, N, Svendsen, J H, Nørgaard, B L & Søndergaard, L 2022, ' Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation ', EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 17, no. 13, pp. 1061-1069 . https://doi.org/10.4244/EIJ-D-21-00363
EuroIntervention
EuroIntervention
BACKGROUND: There are limited data on the association of membranous septum (MS) morphology and transcatheter heart valve (THV) implantation depth, and the development of new conduction abnormalities (CA) after transcatheter aortic valve implantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95962642f04302f61190c80a91b6dc67
https://pure.au.dk/portal/da/publications/membranous-septum-morphology-and-risk-of-conduction-abnormalities-after-transcatheter-aortic-valve-implantation(e789276a-3f53-47d0-bebf-6d67d0012969).html
https://pure.au.dk/portal/da/publications/membranous-septum-morphology-and-risk-of-conduction-abnormalities-after-transcatheter-aortic-valve-implantation(e789276a-3f53-47d0-bebf-6d67d0012969).html
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 98(2)
AIMS Early discharge after transcatheter aortic valve implantation (TAVI) may potentially impact post-procedural safety of the patient. The study aim was to compare safety of TAVI in patients planned for fast track hospital stay with patients planned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88ccb4aae0575a1bc099c7c971a4bf6
https://pubmed.ncbi.nlm.nih.gov/33241627
https://pubmed.ncbi.nlm.nih.gov/33241627
Autor:
Troels H. Jørgensen, Lars Søndergaard
Publikováno v:
JACC Cardiovasc Interv
BACKGROUND: Preexisting and new-onset atrial fibrillation (AF) in patients undergoing transcatheter aortic valve replacement (TAVR) are associated with poor outcomes. OBJECTIVES: This study evaluates impact of new-onset and preexisting AF on TAVR lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf86136eddf745254e6a0c762b2f660
https://doi.org/10.1016/j.jcin.2019.07.008
https://doi.org/10.1016/j.jcin.2019.07.008
Autor:
Lars Søndergaard, Peter Skov Olsen, Hans Gustav Hørsted Thyregod, Nikolaj Ihlemann, Troels H. Jørgensen
Publikováno v:
Journal of the American College of Cardiology. 73:2785-2787
We thank Dr. Pollari and colleagues and Dr. Tang and colleagues for their letters and interest in our paper [(1)][1]. The introduction of transcatheter aortic valve replacement (TAVR) has facilitated an evidence-based paradigm shift in the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d48fde485905292710baeefc604dda8d
https://doi.org/10.1016/j.jacc.2019.04.001
https://doi.org/10.1016/j.jacc.2019.04.001
Autor:
Pablo Codner, Josep Rodés-Cabau, Sabine Bleiziffer, Upul Wickramarachchi, Fadi J. Sawaya, Francesco Maisano, Raj Makkar, Marcus-André Deutsch, Mikko Savontaus, Antonio Mangieri, Maurizio Taramasso, A. Sonia Petronio, Marco Mocetti, Peter Gheeraert, Darren Mylotte, Ran Kornowski, Jason Chan, Johan Bosmans, David Hildick-Smith, Troels H. Jørgensen, Azeem Latib, Thierry Lefèvre, Lars Søndergaard, Ole De Backer, Luigi Biasco, Marco Spaziano, Sung-Han Yoon, Horst Sievert, Moritz Seiffert
Publikováno v:
JACC: Cardiovascular Interventions. 10:1048-1056
Objectives The aim of this study was to evaluate the use of transcatheter heart valves (THV) for the treatment of noncalcific pure native aortic valve regurgitation (NAVR) and failing bioprosthetic surgical heart valves (SHVs) with pure severe aortic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5122207b361a4a815f2b3861ec8223a9
https://doi.org/10.1016/j.jcin.2017.03.004
https://doi.org/10.1016/j.jcin.2017.03.004
Publikováno v:
JACC: Cardiovascular Interventions. 11:404-406
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b83bd033e6fad39fe241496c5b26499
https://doi.org/10.1016/j.jcin.2017.12.017
https://doi.org/10.1016/j.jcin.2017.12.017